<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02147613</url>
  </required_header>
  <id_info>
    <org_study_id>Mayo-ArizonaSU Seed 93016001</org_study_id>
    <nct_id>NCT02147613</nct_id>
  </id_info>
  <brief_title>High Intensity Interval Exercise in Diastolic Heart Failure</brief_title>
  <official_title>High-intensity Aerobic Interval Training vs. Moderate-intensity Continuous Exercise Training in Heart Failure With Preserved Ejection Fraction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Arizona State University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Alberta</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Arizona State University</source>
  <brief_summary>
    <textblock>
      Heart failure is a major health concern and is the leading cause of hospitalization among
      elderly Americans. Currently 5.7 million Americans are estimated to have heart failure and
      the estimated direct and indirect costs of treating heart failure are approximately $37.2
      billion. Approximately 40% of those diagnosed with heart failure will have heart failure with
      preserved ejection fraction (HFPEF). These individuals have significant restrictions in their
      ability to carry out activities of daily living. Exercise training has been established as
      adjuvant therapy in heart failure. Although exercise training guidelines for treatment of
      heart failure with reduced ejection fraction (HFREF) are well established, no consensus
      exercise guidelines exist for management of HFPEF. Aerobic and cardiovascular adaptations are
      generally greater after high-intensity exercise training; interval-type exercise facilitates
      this type of training because it allows for rest periods that make it possible for patients
      with heart failure to perform short (e.g., 1-4 minutes) work periods at intensities that are
      higher than would be possible during continuous exercise. High-intensity aerobic interval
      training presents a unique, yet untested, therapeutic modality for the exercise training of
      patients with heart failure with preserved ejection fraction. Pilot testing is warranted,
      results of which may have important implications for reducing cardiovascular risk, increasing
      short- and long-term quality of life and survival, and reducing healthcare costs in this
      patient population. The investigators primary specific aim is to determine the efficacy of a
      novel, high-intensity aerobic interval exercise training program for improving VO2peak (peak
      oxygen uptake), endothelial function, and arterial stiffness in patients with HFPEF. The
      investigators secondary aim is to determine whether the vascular changes are correlated with
      the changes in VO2peak.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Heart failure is a major health concern and is the leading cause of hospitalization among
      elderly Americans. Currently 5.7 million Americans are estimated to have heart failure and
      the estimated direct and indirect costs of treating heart failure are approximately $37.2
      billion. Approximately 40% of those diagnosed with heart failure will have heart failure with
      preserved ejection fraction (HFPEF).2 These individuals have significant restrictions in
      their ability to carry out activities of daily living.

      Exercise training has been established as adjuvant therapy in heart failure.4 Although
      exercise training guidelines for treatment of heart failure with reduced ejection fraction
      (HFREF) are well established, no consensus exercise guidelines exist for management of HFPEF.
      Exercise training increases VO2peak, thus improving prognosis for patients with heart
      failure. Indeed, VO2peak has been reported to be the single best predictor of mortality in
      those with cardiac disease.6 Exercise training also improves endothelial function and reduces
      arterial stiffness, as well as enhancing quality of life.7,8 Because HFPEF is associated with
      a both diastolic dysfunction and a loss of compensatory systemic vasodilator reserves,
      arterial stiffness and endothelial function are especially important in this population.

      Aerobic and cardiovascular adaptations are generally greater after high-intensity exercise
      training; interval-type exercise facilitates this type of training because it allows for rest
      periods that make it possible for patients with heart failure to perform short (e.g., 1-4
      minutes) work periods at intensities that are higher than would be possible during continuous
      exercise. For example, Wisloff et al. demonstrated the superiority of high-intensity aerobic
      interval training, as compared to continuous, moderate-intensity exercise training, in
      patients with stable postinfarction heart failure (with reduced ejection fraction). Not only
      was VO2peak and FMD improved more, patients tolerated the high-intensity program without
      reported incident. Furthermore, they found it &quot;motivating to have a varied procedure to
      follow,&quot; whereas patients found the continuous exercise group training sessions to be &quot;quite
      boring.&quot; High-intensity aerobic interval training presents a unique, yet untested,
      therapeutic modality for the exercise training of patients with heart failure with preserved
      ejection fraction.

      Pilot testing is warranted, results of which may have important implications for reducing
      cardiovascular risk, increasing short- and long-term quality of life and survival, and
      reducing healthcare costs in this patient population.Patients undergoing exercise training
      live on average 2.16 years longer at the extremely low cost-effectiveness ratio of $1494 per
      life year saved.Since the majority of this patient population belongs to the Medicare age
      group, this intervention has significant potential to reduce healthcare costs.

      Hypotheses and Specific Aims Our primary specific aim is to determine the efficacy of a
      novel, high-intensity aerobic interval exercise training program for improving VO2peak,
      endothelial function, and arterial stiffness in patients with HFPEF. Our secondary aim is to
      determine whether the vascular changes are correlated with the changes in VO2peak.

      We hypothesize that improvements in VO2peak, endothelial function, and arterial stiffness
      will be greater after the high-intensity aerobic interval training program and that vascular
      adaptations will be correlated with changes in VO2peak.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2010</start_date>
  <completion_date type="Actual">April 2012</completion_date>
  <primary_completion_date type="Actual">April 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Left Ventricular Diastolic Dysfunction</measure>
    <time_frame>Before and after the 1 month exercise intervention</time_frame>
    <description>Measured using left ventricular echocardiography. Diastolic dysfunction is graded as: normal, grade 1, grade 2, grade 3, grade 4. Increasing grade is indicative of worsening LV dysfunction and worse outcomes. Improvement in LV grade is associated with better long term outcomes.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>VO2peak</measure>
    <time_frame>Test carried out before and after the 1 month long exercise intervention.</time_frame>
    <description>Measured using a graded exercise test (modified Bruce protocol) with 12-lead EKG monitoring and ventilatory gas exchange analysis.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Brachial Artery Flow-mediated Dilation</measure>
    <time_frame>Before and after 1-month exercise intervention</time_frame>
    <description>Reactive hyperemia mediated brachial artery dilation will be measured after 5 minutes of ischemia with forearm cuff occlusion. Artery will be continuously monitored using B-mode ultrasound.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">19</enrollment>
  <condition>Diastolic Heart Failure</condition>
  <arm_group>
    <arm_group_label>High intensity interval training</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>High intensity interval training - 3 days per week at 85-90% peak heart rate (4x4 bouts) for 1 month (12 sessions of exercise)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Moderate intensity exercise training</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>3 days/week, 30 mins at 70% Peak heart rate for 1 month (12 sessions of exercise)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>High intensity interval training</intervention_name>
    <description>3 days per week at 85-90% peak heart rate (4x4 bouts) for 1 month (12 sessions of exercise)</description>
    <arm_group_label>High intensity interval training</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Moderate intensity exercise training</intervention_name>
    <description>3 days/week, 30 mins at 70% Peak heart rate for 1 month (12 sessions of exercise)</description>
    <arm_group_label>Moderate intensity exercise training</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  HFpEF diagnosis with New York Heart Association heart failure Class II-III symptoms

        Exclusion Criteria:

          -  Unstable angina

          -  Myocardial infarction in the past 4 weeks

          -  Uncompensated heart failure

          -  New York Heart Association class IV symptoms

          -  Complex ventricular arrhythmias (at rest or during the maximal exercise test)

          -  Medical or orthopedic conditions that precluded treadmill walking

          -  Symptomatic severe aortic stenosis

          -  Acute pulmonary embolus

          -  Acute myocarditis

          -  Medication non-compliance
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Arizona State University</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85004</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Scottsdale</city>
        <state>Arizona</state>
        <zip>85259</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2019</verification_date>
  <study_first_submitted>May 21, 2014</study_first_submitted>
  <study_first_submitted_qc>May 27, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 28, 2014</study_first_posted>
  <results_first_submitted>October 5, 2017</results_first_submitted>
  <results_first_submitted_qc>April 10, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">April 12, 2019</results_first_posted>
  <last_update_submitted>April 10, 2019</last_update_submitted>
  <last_update_submitted_qc>April 10, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 12, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Heart Failure, Diastolic</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>High Intensity Interval Training</title>
          <description>High intensity interval training - 3 days per week at 85-90% peak heart rate (4x4 bouts) for 1 month (12 sessions of exercise)
High intensity interval training: 3 days per week at 85-90% peak heart rate (4x4 bouts) for 1 month (12 sessions of exercise)</description>
        </group>
        <group group_id="P2">
          <title>Moderate Intensity Exercise Training</title>
          <description>3 days/week, 30 mins at 70% Peak heart rate for 1 month (12 sessions of exercise)
Moderate intensity exercise training: 3 days/week, 30 mins at 70% Peak heart rate for 1 month (12 sessions of exercise)</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="9"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="6"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>High Intensity Interval Training</title>
          <description>High intensity interval training - 3 days per week at 85-90% peak heart rate (4x4 bouts) for 1 month (12 sessions of exercise)
High intensity interval training: 3 days per week at 85-90% peak heart rate (4x4 bouts) for 1 month (12 sessions of exercise)</description>
        </group>
        <group group_id="B2">
          <title>Moderate Intensity Exercise Training</title>
          <description>3 days/week, 30 mins at 70% Peak heart rate for 1 month (12 sessions of exercise)
Moderate intensity exercise training: 3 days/week, 30 mins at 70% Peak heart rate for 1 month (12 sessions of exercise)</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="10"/>
            <count group_id="B2" value="9"/>
            <count group_id="B3" value="19"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <population>Subjects who completed</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="9"/>
                    <count group_id="B2" value="6"/>
                    <count group_id="B3" value="15"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <population>Mean age of participants that completed the study</population>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <title>Mean age of completers</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="9"/>
                    <count group_id="B2" value="6"/>
                    <count group_id="B3" value="15"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="69" spread="6.1"/>
                    <measurement group_id="B2" value="71.5" spread="11.7"/>
                    <measurement group_id="B3" value="69.9" spread="8.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <population>Composition of participants that completed</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="9"/>
                    <count group_id="B2" value="6"/>
                    <count group_id="B3" value="15"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="10"/>
                    <count group_id="B2" value="9"/>
                    <count group_id="B3" value="19"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Left Ventricular Diastolic Dysfunction</title>
        <description>Measured using left ventricular echocardiography. Diastolic dysfunction is graded as: normal, grade 1, grade 2, grade 3, grade 4. Increasing grade is indicative of worsening LV dysfunction and worse outcomes. Improvement in LV grade is associated with better long term outcomes.</description>
        <time_frame>Before and after the 1 month exercise intervention</time_frame>
        <group_list>
          <group group_id="O1">
            <title>High Intensity Interval Training</title>
            <description>High intensity interval training - 3 days per week at 85-90% peak heart rate (4x4 bouts) for 1 month (12 sessions of exercise)
High intensity interval training: 3 days per week at 85-90% peak heart rate (4x4 bouts) for 1 month (12 sessions of exercise)</description>
          </group>
          <group group_id="O2">
            <title>Moderate Intensity Exercise Training</title>
            <description>3 days/week, 30 mins at 70% Peak heart rate for 1 month (12 sessions of exercise)
Moderate intensity exercise training: 3 days/week, 30 mins at 70% Peak heart rate for 1 month (12 sessions of exercise)</description>
          </group>
        </group_list>
        <measure>
          <title>Left Ventricular Diastolic Dysfunction</title>
          <description>Measured using left ventricular echocardiography. Diastolic dysfunction is graded as: normal, grade 1, grade 2, grade 3, grade 4. Increasing grade is indicative of worsening LV dysfunction and worse outcomes. Improvement in LV grade is associated with better long term outcomes.</description>
          <units>DD grade</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="9"/>
                <count group_id="O2" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pre</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.1" spread="0.3"/>
                    <measurement group_id="O2" value="2" spread="0.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.3" spread="0.7"/>
                    <measurement group_id="O2" value="2.2" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>VO2peak</title>
        <description>Measured using a graded exercise test (modified Bruce protocol) with 12-lead EKG monitoring and ventilatory gas exchange analysis.</description>
        <time_frame>Test carried out before and after the 1 month long exercise intervention.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>High Intensity Interval Training</title>
            <description>High intensity interval training - 3 days per week at 85-90% peak heart rate (4x4 bouts) for 1 month (12 sessions of exercise)
High intensity interval training: 3 days per week at 85-90% peak heart rate (4x4 bouts) for 1 month (12 sessions of exercise)</description>
          </group>
          <group group_id="O2">
            <title>Moderate Intensity Exercise Training</title>
            <description>3 days/week, 30 mins at 70% Peak heart rate for 1 month (12 sessions of exercise)
Moderate intensity exercise training: 3 days/week, 30 mins at 70% Peak heart rate for 1 month (12 sessions of exercise)</description>
          </group>
        </group_list>
        <measure>
          <title>VO2peak</title>
          <description>Measured using a graded exercise test (modified Bruce protocol) with 12-lead EKG monitoring and ventilatory gas exchange analysis.</description>
          <units>ml/kg/min</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="9"/>
                <count group_id="O2" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pre</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19.2" spread="5.2"/>
                    <measurement group_id="O2" value="16.9" spread="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21" spread="5.2"/>
                    <measurement group_id="O2" value="16.8" spread="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Brachial Artery Flow-mediated Dilation</title>
        <description>Reactive hyperemia mediated brachial artery dilation will be measured after 5 minutes of ischemia with forearm cuff occlusion. Artery will be continuously monitored using B-mode ultrasound.</description>
        <time_frame>Before and after 1-month exercise intervention</time_frame>
        <group_list>
          <group group_id="O1">
            <title>High Intensity Interval Training</title>
            <description>High intensity interval training - 3 days per week at 85-90% peak heart rate (4x4 bouts) for 1 month (12 sessions of exercise)
High intensity interval training: 3 days per week at 85-90% peak heart rate (4x4 bouts) for 1 month (12 sessions of exercise)</description>
          </group>
          <group group_id="O2">
            <title>Moderate Intensity Exercise Training</title>
            <description>3 days/week, 30 mins at 70% Peak heart rate for 1 month (12 sessions of exercise)
Moderate intensity exercise training: 3 days/week, 30 mins at 70% Peak heart rate for 1 month (12 sessions of exercise)</description>
          </group>
        </group_list>
        <measure>
          <title>Brachial Artery Flow-mediated Dilation</title>
          <description>Reactive hyperemia mediated brachial artery dilation will be measured after 5 minutes of ischemia with forearm cuff occlusion. Artery will be continuously monitored using B-mode ultrasound.</description>
          <units>percentage of FMD</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="9"/>
                <count group_id="O2" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pre</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.9" spread="3.7"/>
                    <measurement group_id="O2" value="8.1" spread="4.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7" spread="4.2"/>
                    <measurement group_id="O2" value="3.4" spread="3.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>High Intensity Interval Training</title>
          <description>High intensity interval training - 3 days per week at 85-90% peak heart rate (4x4 bouts) for 1 month (12 sessions of exercise)
High intensity interval training: 3 days per week at 85-90% peak heart rate (4x4 bouts) for 1 month (12 sessions of exercise)</description>
        </group>
        <group group_id="E2">
          <title>Moderate Intensity Exercise Training</title>
          <description>3 days/week, 30 mins at 70% Peak heart rate for 1 month (12 sessions of exercise)
Moderate intensity exercise training: 3 days/week, 30 mins at 70% Peak heart rate for 1 month (12 sessions of exercise)</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Siddhartha S. Angadi, PhD., FACSM</name_or_title>
      <organization>Arizona State University - Downtown Phoenix Campus</organization>
      <phone>6028272254</phone>
      <email>sangadi@asu.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

